DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation

Biochemical and Biophysical Research Communications

Volumn 360, Issue 3, 2007, Pages 600-603

  Collado, Denise ^a   Yoshihara, Takashi ^a   Hamaguchi, Masaaki ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

26S Proteasome; CCND1; DBC2; Ecdysone; Inducible gene expression system; Protein degradation; T 47D

Indexed keywords

PROTEASOME; PROTEIN SUBUNIT;

ARTICLE; BREAST CANCER; CELL GROWTH; CELL SURVIVAL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; STEM CELL; TUMOR CELL; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; DRUG RESISTANCE, NEOPLASM; ECDYSTERONE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GTP-BINDING PROTEINS; HUMANS; LEUPEPTINS; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSGENES; TUMOR SUPPRESSOR PROTEINS;

EID: 34447272948     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.127     Document Type: Article

References (8)

1. Yoshihara T., Collado D., and Hamaguchi M. Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function. Biochem. Biophys. Res. Commun. 358 (2007) 1076-1079
2. Hamaguchi M., Meth J.L., Von Klitzing C., Wei W., Esposito D., Rodgers L., Walsh T., Welcsh P., King M.C., and Wigler M.H. DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc. Natl. Acad. Sci. USA 99 (2002) 13647-13652
3. Chang F.K., Sato N., Kobayashi-Simorowski N., Yoshihara T., Meth J.L., and Hamaguchi M. DBC2 is essential for transporting vesicular stomatitis virus glycoprotein. J. Mol. Biol. 364 (2006) 302-308
4. Wilkins A., Ping Q., and Carpenter C.L. RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex. Genes Dev. 18 (2004) 856-861
5. Niedzwiecka A., Marcotrigiano J., Stepinski J., Jankowska-Anyszka M., Wyslouch-Cieszynska A., Dadlez M., Gingras A.C., Mak P., Darzynkiewicz E., Sonenberg N., Burley S.K., and Stolarski R. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5′ cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. J. Mol. Biol. 319 (2002) 615-635
6. Topisirovic I., Culjkovic B., Cohen N., Perez J.M., Skrabanek L., and Borden K.L. The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth. EMBO J. 22 (2003) 689-703
7. Siripurapu V., Meth J.L., Kobayashi N., and Hamaguchi M. DBC2 significantly influences cell cycle, apoptosis, cytoskeleton and membrane trafficking pathways. J. Mol. Biol. 346 (2005) 83-89
8. Stolarov J., Chang K., Reiner A., Rodgers L., Hannon G.J., Wigler M.H., and Mittal V. Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor. Proc. Natl. Acad. Sci. USA 98 (2001) 13043-13048